Mesoblast Ltd (MSB)

0.955
+0.010(+1.06%)
  • Volume:
    382,587
  • Bid/Ask:
    0.955/0.960
  • Day's Range:
    0.940 - 0.970

MSB Overview

Prev. Close
0.945
Day's Range
0.94-0.97
Revenue
8.26M
Open
0.94
52 wk Range
0.61-1.29
EPS
-0.129
Volume
382,587
Market Cap
709.32M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
909,438
P/E Ratio
-5.31
Beta
2.5
1-Year Change
-11.47%
Shares Outstanding
736,578,315
Next Earnings Date
22 Feb 2023
What is your sentiment on Mesoblast?
or
Market is currently closed. Voting is open during market hours.

Mesoblast Ltd News

  • ASX Trades Higher as Tech Recovers
    • ByInvesting.com-

    By Oliver Gray  Investing.com - The ASX 200 was 67.60 points or 0.91% higher at 7,457.70 in Wednesday’s mid-morning deals, with market participants tracking an overnight rally on...

Mesoblast Ltd Analysis

Mesoblast Ltd Company Profile

Mesoblast Ltd Company Profile

Mesoblast Limited is an Australia-based company that is engaged in the development of regenerative medicine products. The Company’s primary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. It has applied its mesenchymal lineage cell technology platform to the allogeneic cellular medicines portfolio in the industry. Its technology addresses multiple inflammatory conditions with unmet medical needs. The Company’s portfolio of Phase III product candidates comprises remestemcel-L for steroid-refractory acute graft versus host disease (acute GVHD), as well as for the treatment of moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection, Revascor for advanced chronic heart failure and MPC-06-ID for chronic low back pain due to degenerative disc disease. The Company’s subsidiaries include Mesoblast, Inc., Mesoblast International Sarl, Mesoblast Australia Pty Ltd, Mesoblast UK Ltd and BeiCell Ltd.

Read More

Analyst Price Target

Average2.385 (+149.749% Upside)
High6.000
Low0.9056
Price0.955
No. of Analysts4
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellNeutralBuySell
Technical IndicatorsSellSellBuyStrong BuyStrong Sell
SummaryStrong SellSellNeutralStrong BuyStrong Sell
  • i don't understand anything here
    0
    • am new an in I don't understand anything here
      0
      • just buy
        2
        • what is the update for MSB? Buy, Hold or Sell?
          0
          • what is the update for MSB? Buy, Hold or Sell?
            0
            • Watch the sellout tomorrow
              0
              • in my opinion msb will recover quite quickly from current share price. its a lot happening in US including th election. I would be worry if this is the only product they have inline but they have other products which are currently in stage 3 and some will soon be going for fda approval." be greedy when others are fearful " warren buffett
                4
                • It has been a on indicative sell for the lst few weeksAfter that hitThe indicators and MA will promote a further sellThere may be bullish rally due to the fact of how cheap it is since it hasnt dropped this low since 2016But that wont last long as there will be drastic pullback till they prove the product and build investor confident back up
                  1
              • in my opinion msb will recover quite quickly from current share price. its a lot happening in US including th election. I would be worry if this is the only product they have inline but they have other products which are currently in stage 3 and some will soon be going for fda approval." be greedy when others are fearful " warren buffett
                2
                • Buy or Sell?
                  2
                  • if you think they have more ammo in the bank to prove themselves to the FDA - it's shopping time!
                    0
                  • Definitely sell, the sentiment is bearish. The share price will not bounce in the foreseeable future unless treatment efficacy is further substantiated & FDA approval is granted. There is a long way to go before this happens.
                    0
                  • George SalmaStotally agree, thats what i said. Absolute gamble if you buy, youre more likely to win against the casino than to make money on this share. A buy would be around the march low, $1 something
                    0
                • overpriced in my opinion
                  4
                  • based on what just happened. it dropped due to FDA not being in favour. time to buy very soon. price drop for some yum yum
                    0
                  • based on what just happened. it dropped due to FDA not being in favour. time to buy very soon. price drop for some yum yum
                    0
                  • tu nguyena buy at its march low is a buy for a quick buck
                    0